In vivo and in vitro anti-inflammatory activity of Lentinus polychrous extract

J Ethnopharmacol. 2013 Jun 3;147(3):631-7. doi: 10.1016/j.jep.2013.03.055. Epub 2013 Mar 29.

Abstract

Ethnopharmacological relevance: Lentinus polychrous is a Thai local edible mushroom, traditionally used for the treatments of fever and inflammation due to snake or scorpion envenomation.

Aim of study: The present study aimed to investigate an anti-inflammatory effect of Lentinus polychrous mycelial extract (LPME) both in vitro and in vivo.

Materials and methods: The cytotoxicity and suppressive effects of LPME on nitric oxide production, intracellular O2(-) production, pro-inflammatory mediator expression, TNF-α production were determined by using LPS-activated RAW 264.7 cells. In addition, Anti-inflammatory effect of LPME was evaluated by using carageenan-induced paw edema in rats.

Results: The LPME exhibited cytotoxicity with 50% inhibitory concentration (IC50) of 280.25 ± 10.10 μg/ml and significantly suppressed the productions of NO and intracellular O2(-) with dose-dependent manner. LPME decreased the expressions of iNOS, IL-1β, IL-6, TNF-α and COX-2 and significantly decreased the TNF-α production in LPS-activated macrophage with dose-dependent manners. Moreover, LPME showed significant suppressive effect on paw edema in rats.

Conclusion: The results clearly revealed that the LPME inhibited NO and pro-inflammatory productions by down-regulating the gene expressions of pro-inflammatory mediators leading to the decrease paw edema in rat which support the traditional use.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Carrageenan
  • Cell Line
  • Cell Survival
  • Complex Mixtures / pharmacology
  • Complex Mixtures / therapeutic use*
  • Cyclooxygenase 1 / genetics
  • Cyclooxygenase 2 / genetics
  • Cytokines / genetics
  • Cytokines / metabolism
  • Edema / chemically induced
  • Edema / drug therapy*
  • Gene Expression Regulation / drug effects
  • Lentinula*
  • Lipopolysaccharides
  • Male
  • Medicine, Traditional
  • Membrane Proteins / genetics
  • Mice
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism
  • Thailand

Substances

  • Anti-Inflammatory Agents
  • Complex Mixtures
  • Cytokines
  • Lipopolysaccharides
  • Membrane Proteins
  • Reactive Oxygen Species
  • Nitric Oxide
  • Carrageenan
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Ptgs2 protein, mouse
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Ptgs1 protein, mouse